The Center for Global Safe Water in the Rollins School of Public Health, Emory University, has received a $2.5 million grant from the Bill & Melinda Gates Foundation to study ways in which individuals are exposed to human waste in cities of the developing world.
For decades, cities in the developing world have continued to grow rapidly without improving water and waste disposal infrastructure. According to World Health Organization (WHO) estimates, 2.6 billion individuals worldwide do not have access to toilets or sanitation facilities, and approximately 884 million people do not have access to clean drinking water. Globally, children remain the primary victims of illnesses related to poor water and sanitation.
The Center for Global Safe Water welcomes new Associate Director, Anil Vora
The Center for Global Safe Water at Emory is pleased to welcome Anil Vora as the Associate Director of Programs. Anil will be based in the Hubert Department of Global Health at the Rollins School of Public Health at Emory and will be primarily responsible for strategic planning and development, program management and partnerships at the Center. Over the next few weeks, he will be meeting with many of you to learn more about your work and involvement in the Center Anil comes to us from the Bill & Melinda Gates Foundation where he spent nearly four years managing a wide ranging portfolio of grants. Most recently, he served as program manager for the foundation’s developing program in India, including $100 million in grants and contracts to improve health outcomes for mothers and children in the state of Bihar. While at the foundation, he also worked in other strategic priorities such as polio eradication, human resources and capacity building in Africa, and tobacco control efforts in Africa and Southeast Asia. Anil’s background includes eight years at Group Health Research Institute (GHRI) in Seattle, Washington as project coordinator for a team that conducted clinical and epidemiological research in uptake and efficacy of childhood and adult vaccines including influenza, pneumococcal, meningococcal, DTaP, and avian flu vaccines. Anil’s final effort at GHRI was in assisting the team to write and secure $25 million, 7-year funding for GHRI as one of the sites in the national Vaccine Treatment and Evaluation Unit (VTEU) funded by the NIH. Anil’s public health experience also includes ten years working in HIV prevention education in Southern California and Seattle.
Please excuse broken links as this site is still under construction. For more information or to contact the Center staff, please email Kathleen Peters.